Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6344.0000
-48.50
(
-0.76
%)
NSE
Jan 01, 2026
15:31 PM
28.03% Gain from 52W Low
Volume:
146.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
06 Nov 2023
6344.00
-0.76%
Pricing pressure in API segment hurts profitability
Neutral:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 3330
Target
Motilal Oswal
Divi's Laboratories .. has an
average target
of 6432.50 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Will the smallcap investor run out of patience in 2026?
The Baseline |
01 Jan 2026, 11:23AM
Market closes higher amid strong buying in steel stocks
Trendlyne Marketwatch |
31 Dec 2025, 04:01PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022